<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rice BA</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>2854-2863.e2</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10247898</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(11)</volume><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>While heavy alcohol use consistently associates with liver disease, the effects of nonheavy alcohol consumption are less understood. We aimed to investigate the relationship between nonheavy alcohol use and chronic liver disease.&lt;h4>Methods&lt;/h4>This cross-sectional study included 2629 current drinkers in the Framingham Heart Study who completed alcohol use questionnaires and transient elastography. We defined fibrosis as liver stiffness measurement (LSM) ≥8.2 kPa. We defined at-risk nonalcoholic steatohepatitis (NASH) as FibroScan-aspartate aminotransferase (FAST) score >0.35 (90% sensitivity) or ≥0.67 (90% specificity). We performed logistic regression to investigate associations of alcohol use measures with fibrosis and NASH, adjusting for sociodemographic and</pubmed_abstract><journal>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</journal><pubmed_title>Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study.</pubmed_title><pmcid>PMC10247898</pmcid><funding_grant_id>HHSN268201500001C</funding_grant_id><funding_grant_id>UL1 TR001430</funding_grant_id><funding_grant_id>K23 DK113252</funding_grant_id><funding_grant_id>75N92019D00031</funding_grant_id><funding_grant_id>HHSN268201500001I</funding_grant_id><funding_grant_id>N01HC25195</funding_grant_id><pubmed_authors>Naimi TS</pubmed_authors><pubmed_authors>Rice BA</pubmed_authors><pubmed_authors>Long MT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study.</name><description>&lt;h4>Background and aims&lt;/h4>While heavy alcohol use consistently associates with liver disease, the effects of nonheavy alcohol consumption are less understood. We aimed to investigate the relationship between nonheavy alcohol use and chronic liver disease.&lt;h4>Methods&lt;/h4>This cross-sectional study included 2629 current drinkers in the Framingham Heart Study who completed alcohol use questionnaires and transient elastography. We defined fibrosis as liver stiffness measurement (LSM) ≥8.2 kPa. We defined at-risk nonalcoholic steatohepatitis (NASH) as FibroScan-aspartate aminotransferase (FAST) score >0.35 (90% sensitivity) or ≥0.67 (90% specificity). We performed logistic regression to investigate associations of alcohol use measures with fibrosis and NASH, adjusting for sociodemographic and</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2025-04-04T18:52:30.16Z</modification><creation>2025-04-04T18:52:30.16Z</creation></dates><accession>S-EPMC10247898</accession><cross_references><pubmed>36503167</pubmed><doi>10.1016/j.cgh.2022.10.039</doi></cross_references></HashMap>